{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:20:13Z","timestamp":1792686013590,"version":"4.5.0"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T00:00:00Z","timestamp":1745884800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Metab Brain Dis"],"DOI":"10.1007\/s11011-025-01623-9","type":"journal-article","created":{"date-parts":[[2025,4,29]],"date-time":"2025-04-29T07:04:06Z","timestamp":1745910246000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["A second act for spironolactone: cognitive benefits in renal dysfunction \u2013 a critical review"],"prefix":"10.1007","volume":"40","author":[{"given":"Akhil","family":"Sharma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashi","family":"Mannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shareen","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2979-1590","authenticated-orcid":false,"given":"Thakur Gurjeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,29]]},"reference":[{"key":"1623_CR1","doi-asserted-by":"publisher","first-page":"850","DOI":"10.3390\/jcm8060850","volume":"8","author":"A Ahmad","year":"2019","unstructured":"Ahmad A, Ali T, Rehman SU, Kim MO (2019) Phytomedicine-based potent antioxidant, fisetin protects CNS-Insult LPS-induced oxidative stress-mediated neurodegeneration and memory impairment. J Clin Med 8:850. https:\/\/doi.org\/10.3390\/jcm8060850","journal-title":"J Clin Med"},{"key":"1623_CR2","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1007\/s11033-023-09170-1","volume":"51","author":"S Bajaj","year":"2024","unstructured":"Bajaj S, Mahesh R (2024) Converged avenues: depression and Alzheimer\u2019s disease- shared pathophysiology and novel therapeutics. Mol Biol Rep 51:225. https:\/\/doi.org\/10.1007\/s11033-023-09170-1","journal-title":"Mol Biol Rep"},{"key":"1623_CR3","doi-asserted-by":"publisher","first-page":"469","DOI":"10.22038\/ijbms.2019.34037.8095","volume":"22","author":"S Banaei","year":"2019","unstructured":"Banaei S, Rezagholizadeh L (2019) The role of hormones in renal disease and ischemia-reperfusion injury. Iran J Basic Med Sci 22:469\u2013476. https:\/\/doi.org\/10.22038\/ijbms.2019.34037.8095","journal-title":"Iran J Basic Med Sci"},{"key":"1623_CR4","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/nrneph.2013.44","volume":"9","author":"MGH Betjes","year":"2013","unstructured":"Betjes MGH (2013) Immune cell dysfunction and inflammation in end-stage renal disease. Nat Rev Nephrol 9:255\u2013265. https:\/\/doi.org\/10.1038\/nrneph.2013.44","journal-title":"Nat Rev Nephrol"},{"key":"1623_CR5","doi-asserted-by":"publisher","first-page":"60542","DOI":"10.1007\/s11356-022-20106-3","volume":"29","author":"SK Bhargava","year":"2022","unstructured":"Bhargava SK, Singh TG, Mannan A et al (2022) Pharmacological evaluation of Thuja occidentalis for the attenuation of neuropathy via ages and TNF-\u03b1 Inhibition in diabetic neuropathic rats. Environ Sci Pollut Res Int 29:60542\u201360557. https:\/\/doi.org\/10.1007\/s11356-022-20106-3","journal-title":"Environ Sci Pollut Res Int"},{"key":"1623_CR6","doi-asserted-by":"publisher","first-page":"ii55","DOI":"10.1093\/ndt\/gfab261","volume":"37","author":"B Bikbov","year":"2021","unstructured":"Bikbov B, Soler MJ, Pe\u0161i\u0107 V et al (2021) Albuminuria as a risk factor for mild cognitive impairment and dementia-what is the evidence? Nephrol Dial Transpl 37:ii55\u2013ii62. https:\/\/doi.org\/10.1093\/ndt\/gfab261","journal-title":"Nephrol Dial Transpl"},{"key":"1623_CR7","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1681\/ASN.2019070728","volume":"31","author":"M Bobot","year":"2020","unstructured":"Bobot M, Thomas L, Moyon A et al (2020) Uremic toxic blood-brain barrier disruption mediated by AhR activation leads to cognitive impairment during experimental renal dysfunction. J Am Soc Nephrol 31:1509\u20131521. https:\/\/doi.org\/10.1681\/ASN.2019070728","journal-title":"J Am Soc Nephrol"},{"key":"1623_CR8","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1016\/j.neulet.2005.01.031","volume":"380","author":"NI Bohnen","year":"2005","unstructured":"Bohnen NI, Kaufer DI, Hendrickson R et al (2005) Cognitive correlates of alterations in acetylcholinesterase in Alzheimer\u2019s disease. Neurosci Lett 380:127\u2013132. https:\/\/doi.org\/10.1016\/j.neulet.2005.01.031","journal-title":"Neurosci Lett"},{"key":"1623_CR9","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1677\/erc.0.0060315","volume":"6","author":"GD Braunstein","year":"1999","unstructured":"Braunstein GD (1999) Aromatase and gynecomastia. Endocr Relat Cancer 6:315\u2013324. https:\/\/doi.org\/10.1677\/erc.0.0060315","journal-title":"Endocr Relat Cancer"},{"key":"1623_CR10","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/nrneph.2010.30","volume":"6","author":"M Briet","year":"2010","unstructured":"Briet M, Schiffrin EL (2010) Aldosterone: effects on the kidney and cardiovascular system. Nat Rev Nephrol 6:261\u2013273. https:\/\/doi.org\/10.1038\/nrneph.2010.30","journal-title":"Nat Rev Nephrol"},{"key":"1623_CR11","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1159\/000345243","volume":"50","author":"M Briet","year":"2013","unstructured":"Briet M, Schiffrin EL (2013) Vascular actions of aldosterone. J Vasc Res 50:89\u201399. https:\/\/doi.org\/10.1159\/000345243","journal-title":"J Vasc Res"},{"key":"1623_CR12","doi-asserted-by":"publisher","first-page":"2726369","DOI":"10.1155\/2017\/2726369","volume":"2017","author":"UG Bronas","year":"2017","unstructured":"Bronas UG, Puzantian H, Hannan M (2017) Cognitive impairment in chronic kidney disease: vascular milieu and the potential therapeutic role of exercise. Biomed Res Int 2017:2726369. https:\/\/doi.org\/10.1155\/2017\/2726369","journal-title":"Biomed Res Int"},{"key":"1623_CR13","doi-asserted-by":"publisher","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","volume":"79","author":"F Buffolo","year":"2022","unstructured":"Buffolo F, Tetti M, Mulatero P, Monticone S (2022) Aldosterone as a mediator of cardiovascular damage. Hypertension 79:1899\u20131911. https:\/\/doi.org\/10.1161\/HYPERTENSIONAHA.122.17964","journal-title":"Hypertension"},{"key":"1623_CR14","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.3390\/antiox9121303","volume":"9","author":"V Calabrese","year":"2020","unstructured":"Calabrese V, Scuto M, Salinaro AT et al (2020) Hydrogen sulfide and carnosine: modulation of oxidative stress and inflammation in kidney and brain Axis. Antioxid (Basel) 9:1303. https:\/\/doi.org\/10.3390\/antiox9121303","journal-title":"Antioxid (Basel)"},{"key":"1623_CR15","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.biopha.2018.02.090","volume":"101","author":"L Chen","year":"2018","unstructured":"Chen L, Yang T, Lu D-W et al (2018) Central role of dysregulation of TGF-\u03b2\/Smad in CKD progression and potential targets of its treatment. Biomed Pharmacother 101:670\u2013681. https:\/\/doi.org\/10.1016\/j.biopha.2018.02.090","journal-title":"Biomed Pharmacother"},{"key":"1623_CR16","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.pharmthera.2015.07.006","volume":"154","author":"J Deinum","year":"2015","unstructured":"Deinum J, Riksen NP, Lenders JWM (2015) Pharmacological treatment of aldosterone excess. Pharmacol Ther 154:120\u2013133. https:\/\/doi.org\/10.1016\/j.pharmthera.2015.07.006","journal-title":"Pharmacol Ther"},{"key":"1623_CR17","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.brainres.2016.02.034","volume":"1637","author":"QN Dinh","year":"2016","unstructured":"Dinh QN, Young MJ, Evans MA et al (2016) Aldosterone-induced oxidative stress and inflammation in the brain are mediated by the endothelial cell mineralocorticoid receptor. Brain Res 1637:146\u2013153. https:\/\/doi.org\/10.1016\/j.brainres.2016.02.034","journal-title":"Brain Res"},{"key":"1623_CR18","doi-asserted-by":"publisher","first-page":"R944","DOI":"10.1152\/ajpregu.2001.281.3.R944","volume":"281","author":"AM Dorrance","year":"2001","unstructured":"Dorrance AM, Osborn HL, Grekin R, Webb RC (2001) Spironolactone reduces cerebral infarct size and EGF-receptor mRNA in stroke-prone rats. Am J Physiol Regul Integr Comp Physiol 281:R944\u2013950. https:\/\/doi.org\/10.1152\/ajpregu.2001.281.3.R944","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"1623_CR19","doi-asserted-by":"publisher","first-page":"T67","DOI":"10.1530\/JOE-17-0009","volume":"234","author":"JJ DuPont","year":"2017","unstructured":"DuPont JJ, Jaffe IZ (2017) 30 years of the mineralocorticoid receptor: the role of the mineralocorticoid receptor in the vasculature. J Endocrinol 234:T67\u2013T82. https:\/\/doi.org\/10.1530\/JOE-17-0009","journal-title":"J Endocrinol"},{"key":"1623_CR20","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1111\/j.1751-7176.2011.00511.x","volume":"13","author":"M Epstein","year":"2011","unstructured":"Epstein M, Calhoun DA (2011) Aldosterone blockers (mineralocorticoid receptor antagonism) and potassium-sparing diuretics. J Clin Hypertens (Greenwich) 13:644\u2013648. https:\/\/doi.org\/10.1111\/j.1751-7176.2011.00511.x","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"1623_CR21","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1159\/000338135","volume":"35","author":"T Etgen","year":"2012","unstructured":"Etgen T, Chonchol M, F\u00f6rstl H, Sander D (2012) Chronic kidney disease and cognitive impairment: a systematic review and meta-analysis. Am J Nephrol 35:474\u2013482. https:\/\/doi.org\/10.1159\/000338135","journal-title":"Am J Nephrol"},{"key":"1623_CR22","doi-asserted-by":"publisher","first-page":"423","DOI":"10.1053\/j.ajkd.2017.09.026","volume":"71","author":"S Fishbane","year":"2018","unstructured":"Fishbane S, Spinowitz B (2018) Update on anemia in ESRD and earlier stages of CKD: core curriculum 2018. Am J Kidney Dis 71:423\u2013435. https:\/\/doi.org\/10.1053\/j.ajkd.2017.09.026","journal-title":"Am J Kidney Dis"},{"key":"1623_CR23","doi-asserted-by":"publisher","first-page":"941","DOI":"10.3389\/fphar.2017.00941","volume":"8","author":"M Fumagalli","year":"2017","unstructured":"Fumagalli M, Lecca D, Abbracchio MP, Ceruti S (2017) Pathophysiological role of purines and pyrimidines in neurodevelopment: unveiling new pharmacological approaches to congenital brain diseases. Front Pharmacol 8:941. https:\/\/doi.org\/10.3389\/fphar.2017.00941","journal-title":"Front Pharmacol"},{"key":"1623_CR24","doi-asserted-by":"publisher","first-page":"1991","DOI":"10.1007\/s10815-024-03214-6","volume":"41","author":"A Ghofranian","year":"2024","unstructured":"Ghofranian A, Estevez SL, Dubois B et al (2024) Spironolactone use and oocyte maturation in patients undergoing controlled ovarian hyperstimulation. J Assist Reprod Genet 41:1991\u20131996. https:\/\/doi.org\/10.1007\/s10815-024-03214-6","journal-title":"J Assist Reprod Genet"},{"key":"1623_CR25","doi-asserted-by":"publisher","first-page":"R109","DOI":"10.1530\/JME-16-0061","volume":"57","author":"S Giatti","year":"2016","unstructured":"Giatti S, Melcangi RC, Pesaresi M (2016) The other side of progestins: effects in the brain. J Mol Endocrinol 57:R109\u2013126. https:\/\/doi.org\/10.1530\/JME-16-0061","journal-title":"J Mol Endocrinol"},{"key":"1623_CR26","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1038\/nrneph.2016.163","volume":"13","author":"RJ Glassock","year":"2017","unstructured":"Glassock RJ, Warnock DG, Delanaye P (2017) The global burden of chronic kidney disease: estimates, variability and pitfalls. Nat Rev Nephrol 13:104\u2013114. https:\/\/doi.org\/10.1038\/nrneph.2016.163","journal-title":"Nat Rev Nephrol"},{"key":"1623_CR27","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.3389\/fphar.2018.01131","volume":"9","author":"R Gonz\u00e1lez-Bl\u00e1zquez","year":"2018","unstructured":"Gonz\u00e1lez-Bl\u00e1zquez R, Somoza B, Gil-Ortega M et al (2018) Finerenone attenuates endothelial dysfunction and albuminuria in a chronic kidney disease model by a reduction in oxidative stress. Front Pharmacol 9:1131. https:\/\/doi.org\/10.3389\/fphar.2018.01131","journal-title":"Front Pharmacol"},{"key":"1623_CR28","doi-asserted-by":"publisher","first-page":"2672","DOI":"10.1161\/STR.0b013e3182299496","volume":"42","author":"PB Gorelick","year":"2011","unstructured":"Gorelick PB, Scuteri A, Black SE et al (2011) Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American heart association\/american stroke association. Stroke 42:2672\u20132713. https:\/\/doi.org\/10.1161\/STR.0b013e3182299496","journal-title":"Stroke"},{"key":"1623_CR29","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1291\/hypres.31.363","volume":"31","author":"H Hayashi","year":"2008","unstructured":"Hayashi H, Kobara M, Abe M et al (2008) Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis. Hypertens Res 31:363\u2013375. https:\/\/doi.org\/10.1291\/hypres.31.363","journal-title":"Hypertens Res"},{"key":"1623_CR30","doi-asserted-by":"publisher","first-page":"1359","DOI":"10.1038\/s41593-018-0242-x","volume":"21","author":"S Hickman","year":"2018","unstructured":"Hickman S, Izzy S, Sen P et al (2018) Microglia in neurodegeneration. Nat Neurosci 21:1359\u20131369. https:\/\/doi.org\/10.1038\/s41593-018-0242-x","journal-title":"Nat Neurosci"},{"key":"1623_CR31","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1007\/s11030-014-9550-6","volume":"18","author":"S Jain","year":"2014","unstructured":"Jain S, Rathod V, Prajapati R et al (2014) Pregnane X receptor and P-glycoprotein: a connexion for Alzheimer\u2019s disease management. Mol Divers 18:895\u2013909. https:\/\/doi.org\/10.1007\/s11030-014-9550-6","journal-title":"Mol Divers"},{"key":"1623_CR32","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1038\/s41581-018-0098-z","volume":"15","author":"N Jourde-Chiche","year":"2019","unstructured":"Jourde-Chiche N, Fakhouri F, Dou L et al (2019) Endothelium structure and function in kidney health and disease. Nat Rev Nephrol 15:87\u2013108. https:\/\/doi.org\/10.1038\/s41581-018-0098-z","journal-title":"Nat Rev Nephrol"},{"key":"1623_CR33","doi-asserted-by":"publisher","first-page":"786","DOI":"10.1016\/S0140-6736(21)00519-5","volume":"398","author":"K Kalantar-Zadeh","year":"2021","unstructured":"Kalantar-Zadeh K, Jafar TH, Nitsch D et al (2021) Chronic kidney disease. Lancet 398:786\u2013802. https:\/\/doi.org\/10.1016\/S0140-6736(21)00519-5","journal-title":"Lancet"},{"key":"1623_CR34","doi-asserted-by":"publisher","first-page":"237","DOI":"10.3109\/08923973.2014.921690","volume":"36","author":"Y Kato","year":"2014","unstructured":"Kato Y, Kamiya H, Koide N et al (2014) Spironolactone inhibits production of proinflammatory mediators in response to lipopolysaccharide via inactivation of nuclear factor-\u03baB. Immunopharmacol Immunotoxicol 36:237\u2013241. https:\/\/doi.org\/10.3109\/08923973.2014.921690","journal-title":"Immunopharmacol Immunotoxicol"},{"key":"1623_CR35","doi-asserted-by":"publisher","first-page":"122303","DOI":"10.1016\/j.lfs.2023.122303","volume":"336","author":"D Kaur","year":"2024","unstructured":"Kaur D, Khan H, Grewal AK, Singh TG (2024a) Glycosylation: a new signaling paradigm for the neurovascular diseases. Life Sci 336:122303","journal-title":"Life Sci"},{"key":"1623_CR36","doi-asserted-by":"publisher","first-page":"3057","DOI":"10.1007\/s10787-024-01517-9","volume":"32","author":"G Kaur","year":"2024","unstructured":"Kaur G, Devi S, Sharma A, Sood P (2024b) Pharmacological insights and role of Bufalin (bufadienolides) in inflammation modulation: a narrative review. Inflammopharmacology 32:3057\u20133077. https:\/\/doi.org\/10.1007\/s10787-024-01517-9","journal-title":"Inflammopharmacology"},{"key":"1623_CR37","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.kint.2020.11.003","volume":"99","author":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group","year":"2021","unstructured":"Kidney Disease: Improving Global Outcomes (KDIGO) Blood Pressure Work Group (2021) KDIGO 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease. Kidney Int 99:S1\u2013S87. https:\/\/doi.org\/10.1016\/j.kint.2020.11.003","journal-title":"Kidney Int"},{"key":"1623_CR38","doi-asserted-by":"publisher","first-page":"489","DOI":"10.3904\/kjim.2021.492","volume":"37","author":"D-S Kim","year":"2022","unstructured":"Kim D-S, Kim S-W, Gil H-W (2022) Emotional and cognitive changes in chronic kidney disease. Korean J Intern Med 37:489\u2013501. https:\/\/doi.org\/10.3904\/kjim.2021.492","journal-title":"Korean J Intern Med"},{"key":"1623_CR39","doi-asserted-by":"publisher","unstructured":"Kiss A, Acar E, Watzinger S, et al (2020) Two in one: neuregulin 1 improves cardiac diastolic and kindney funtcion in chronic kidney disease in rats. Eur Heart J 41:ehaa946.3670. https:\/\/doi.org\/10.1093\/ehjci\/ehaa946.3670","DOI":"10.1093\/ehjci\/ehaa946.3670"},{"key":"1623_CR40","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1038\/s41401-021-00838-7","volume":"43","author":"N Koju","year":"2022","unstructured":"Koju N, Qin Z-H, Sheng R (2022) Reduced nicotinamide adenine dinucleotide phosphate in redox balance and diseases: a friend or foe? Acta Pharmacol Sin 43:1889\u20131904. https:\/\/doi.org\/10.1038\/s41401-021-00838-7","journal-title":"Acta Pharmacol Sin"},{"key":"1623_CR41","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1007\/s11011-018-0204-8","volume":"33","author":"A Koval\u010d\u00edkov\u00e1","year":"2018","unstructured":"Koval\u010d\u00edkov\u00e1 A, Gyur\u00e1szov\u00e1 M, Vavrincov\u00e1-Yaghi D et al (2018) Oxidative stress in the brain caused by acute kidney injury. Metab Brain Dis 33:961\u2013967. https:\/\/doi.org\/10.1007\/s11011-018-0204-8","journal-title":"Metab Brain Dis"},{"key":"1623_CR42","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1007\/s10571-017-0510-4","volume":"38","author":"P Kowia\u0144ski","year":"2018","unstructured":"Kowia\u0144ski P, Lietzau G, Czuba E et al (2018) BDNF: a key factor with multipotent impact on brain signaling and synaptic plasticity. Cell Mol Neurobiol 38:579\u2013593. https:\/\/doi.org\/10.1007\/s10571-017-0510-4","journal-title":"Cell Mol Neurobiol"},{"key":"1623_CR43","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1038\/ki.2010.336","volume":"79","author":"M Kurella Tamura","year":"2011","unstructured":"Kurella Tamura M, Yaffe K (2011) Dementia and cognitive impairment in ESRD: diagnostic and therapeutic strategies. Kidney Int 79:14\u201322. https:\/\/doi.org\/10.1038\/ki.2010.336","journal-title":"Kidney Int"},{"key":"1623_CR44","doi-asserted-by":"publisher","first-page":"959902","DOI":"10.3389\/fendo.2022.959902","volume":"13","author":"Y Lv","year":"2022","unstructured":"Lv Y, Luo Y-Y, Ren H-W et al (2022) The role of pregnane X receptor (PXR) in substance metabolism. Front Endocrinol (Lausanne) 13:959902. https:\/\/doi.org\/10.3389\/fendo.2022.959902","journal-title":"Front Endocrinol (Lausanne)"},{"key":"1623_CR45","doi-asserted-by":"publisher","first-page":"286","DOI":"10.2174\/1389450122666210707120256","volume":"23","author":"A Mannan","year":"2022","unstructured":"Mannan A, Singh TG, Singh V et al (2022) Insights into the mechanism of the therapeutic potential of herbal monoamine oxidase inhibitors in neurological diseases. Curr Drug Targets 23:286\u2013310. https:\/\/doi.org\/10.2174\/1389450122666210707120256","journal-title":"Curr Drug Targets"},{"key":"1623_CR46","doi-asserted-by":"crossref","unstructured":"Mansour HM, El-Khatib AS (2023) Chap. 10 - Repositioning of receptor tyrosine kinase inhibitors: from cancer to neurodegenerative and psychiatric disorders. In: Mansour HM, Khattab MM, El-khatib AS (eds) Receptor Tyrosine Kinases in Neurodegenerative and Psychiatric Disorders. Academic Press, pp 353\u2013401","DOI":"10.1016\/B978-0-443-18677-6.00010-5"},{"key":"1623_CR47","doi-asserted-by":"publisher","first-page":"172","DOI":"10.3390\/jox13020014","volume":"13","author":"C Martins-Gomes","year":"2023","unstructured":"Martins-Gomes C, Silva AM (2023) Natural products as a tool to modulate the activity and expression of multidrug resistance proteins of intestinal barrier. J Xenobiot 13:172\u2013192. https:\/\/doi.org\/10.3390\/jox13020014","journal-title":"J Xenobiot"},{"key":"1623_CR48","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mehy.2017.12.016","volume":"111","author":"MK Mazumder","year":"2018","unstructured":"Mazumder MK, Phukan BC, Bhattacharjee A, Borah A (2018) Disturbed purine nucleotide metabolism in chronic kidney disease is a risk factor for cognitive impairment. Med Hypotheses 111:36\u201339. https:\/\/doi.org\/10.1016\/j.mehy.2017.12.016","journal-title":"Med Hypotheses"},{"key":"1623_CR49","doi-asserted-by":"publisher","first-page":"647","DOI":"10.3390\/ijms23020647","volume":"23","author":"P Mertowska","year":"2022","unstructured":"Mertowska P, Mertowski S, Smarz-Widelska I, Grywalska E (2022) Biological role, mechanism of action and the importance of interleukins in kidney diseases. Int J Mol Sci 23:647. https:\/\/doi.org\/10.3390\/ijms23020647","journal-title":"Int J Mol Sci"},{"key":"1623_CR50","doi-asserted-by":"publisher","first-page":"1126","DOI":"10.3390\/antiox12051126","volume":"12","author":"M Mladenov","year":"2023","unstructured":"Mladenov M, Lubomirov L, Grisk O et al (2023) Oxidative stress, reductive stress and antioxidants in vascular pathogenesis and aging. Antioxid (Basel) 12:1126. https:\/\/doi.org\/10.3390\/antiox12051126","journal-title":"Antioxid (Basel)"},{"key":"1623_CR51","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1007\/s43440-023-00505-0","volume":"75","author":"M Mohan","year":"2023","unstructured":"Mohan M, Mannan A, Singh TG (2023) Therapeutic implication of Sonic Hedgehog as a potential modulator in ischemic injury. Pharmacol Rep 75:838\u2013860. https:\/\/doi.org\/10.1007\/s43440-023-00505-0","journal-title":"Pharmacol Rep"},{"key":"1623_CR52","doi-asserted-by":"publisher","DOI":"10.2174\/0113894501320839240918110656","author":"M Mohan","year":"2024","unstructured":"Mohan M, Mannan A, Kakkar C, Singh TG (2024) Nrf2 and ferroptosis: exploring translational avenues for therapeutic approaches to neurological diseases. Curr Drug Targets. https:\/\/doi.org\/10.2174\/0113894501320839240918110656","journal-title":"Curr Drug Targets"},{"key":"1623_CR53","doi-asserted-by":"publisher","first-page":"154","DOI":"10.2174\/138920011795016854","volume":"12","author":"K Monostory","year":"2011","unstructured":"Monostory K, Dvorak Z (2011) Steroid regulation of drug-metabolizing cytochromes P450. Curr Drug Metab 12:154\u2013172. https:\/\/doi.org\/10.2174\/138920011795016854","journal-title":"Curr Drug Metab"},{"key":"1623_CR54","doi-asserted-by":"publisher","first-page":"7068","DOI":"10.3748\/wjg.14.7068","volume":"14","author":"A-D Mottino","year":"2008","unstructured":"Mottino A-D, Catania V-A (2008) Hepatic drug transporters and nuclear receptors: regulation by therapeutic agents. World J Gastroenterol 14:7068\u20137074. https:\/\/doi.org\/10.3748\/wjg.14.7068","journal-title":"World J Gastroenterol"},{"key":"1623_CR55","doi-asserted-by":"publisher","first-page":"178","DOI":"10.2174\/1389450116666150825115658","volume":"17","author":"A Muthuraman","year":"2016","unstructured":"Muthuraman A, Kaur P (2016) Renin-Angiotensin-Aldosterone system: a current drug target for the management of neuropathic pain. Curr Drug Targets 17:178\u2013195. https:\/\/doi.org\/10.2174\/1389450116666150825115658","journal-title":"Curr Drug Targets"},{"key":"1623_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.2174\/1570159X22666240320133241","volume":"23","author":"R Naeimi","year":"2024","unstructured":"Naeimi R, Safarpour F, Askari H, Ghasemi-Kasman M (2024) Current insights into the neurotoxicity of melamine: a comprehensive review. Curr Neuropharmacol 23:20\u201335. https:\/\/doi.org\/10.2174\/1570159X22666240320133241","journal-title":"Curr Neuropharmacol"},{"key":"1623_CR57","doi-asserted-by":"publisher","first-page":"2420","DOI":"10.3390\/ijms25042420","volume":"25","author":"GT Nagami","year":"2024","unstructured":"Nagami GT, Kraut JA (2024) The role of the endocrine system in the regulation of acid-base balance by the kidney and the progression of chronic kidney disease. Int J Mol Sci 25:2420. https:\/\/doi.org\/10.3390\/ijms25042420","journal-title":"Int J Mol Sci"},{"key":"1623_CR58","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00228-015-1835-x","volume":"71","author":"FQ Nuttall","year":"2015","unstructured":"Nuttall FQ, Warrier RS, Gannon MC (2015) Gynecomastia and drugs: a critical evaluation of the literature. Eur J Clin Pharmacol 71:569\u2013578. https:\/\/doi.org\/10.1007\/s00228-015-1835-x","journal-title":"Eur J Clin Pharmacol"},{"key":"1623_CR59","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1016\/j.freeradbiomed.2012.05.011","volume":"53","author":"N Queisser","year":"2012","unstructured":"Queisser N, Schupp N (2012) Aldosterone, oxidative stress, and NF-\u03baB activation in hypertension-related cardiovascular and renal diseases. Free Radic Biol Med 53:314\u2013327. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2012.05.011","journal-title":"Free Radic Biol Med"},{"key":"1623_CR60","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/s0014-2999(00)00677-4","volume":"405","author":"JM Reul","year":"2000","unstructured":"Reul JM, Gesing A, Droste S et al (2000) The brain mineralocorticoid receptor: greedy for ligand, mysterious in function. Eur J Pharmacol 405:235\u2013249. https:\/\/doi.org\/10.1016\/s0014-2999(00)00677-4","journal-title":"Eur J Pharmacol"},{"key":"1623_CR61","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.tox.2011.03.015","volume":"285","author":"JP Rigalli","year":"2011","unstructured":"Rigalli JP, Ruiz ML, Perdomo VG et al (2011) Pregnane X receptor mediates the induction of P-glycoprotein by spironolactone in HepG2 cells. Toxicology 285:18\u201324. https:\/\/doi.org\/10.1016\/j.tox.2011.03.015","journal-title":"Toxicology"},{"key":"1623_CR62","doi-asserted-by":"publisher","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","volume":"283","author":"R Rocha","year":"2002","unstructured":"Rocha R, Rudolph AE, Frierdich GE et al (2002) Aldosterone induces a vascular inflammatory phenotype in the rat heart. Am J Physiol Heart Circ Physiol 283:H1802\u20131810. https:\/\/doi.org\/10.1152\/ajpheart.01096.2001","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"1623_CR63","doi-asserted-by":"publisher","first-page":"17088","DOI":"10.1038\/nrdp.2017.88","volume":"3","author":"P Romagnani","year":"2017","unstructured":"Romagnani P, Remuzzi G, Glassock R et al (2017) Chronic kidney disease. Nat Rev Dis Primers 3:17088. https:\/\/doi.org\/10.1038\/nrdp.2017.88","journal-title":"Nat Rev Dis Primers"},{"key":"1623_CR64","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.2215\/CJN.02660221","volume":"16","author":"MH Rosner","year":"2021","unstructured":"Rosner MH, Reis T, Husain-Syed F et al (2021) Classification of uremic toxins and their role in kidney failure. Clin J Am Soc Nephrol 16:1918\u20131928. https:\/\/doi.org\/10.2215\/CJN.02660221","journal-title":"Clin J Am Soc Nephrol"},{"key":"1623_CR65","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1212\/WNL.0000000000001741","volume":"85","author":"S Sedaghat","year":"2015","unstructured":"Sedaghat S, Cremers LGM, de Groot M et al (2015) Kidney function and microstructural integrity of brain white matter. Neurology 85:154\u2013161. https:\/\/doi.org\/10.1212\/WNL.0000000000001741","journal-title":"Neurology"},{"key":"1623_CR66","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1159\/000453028","volume":"2","author":"JL Seifter","year":"2017","unstructured":"Seifter JL, Chang H-Y (2017) Disorders of Acid-Base balance: new perspectives. Kidney Dis (Basel) 2:170\u2013186. https:\/\/doi.org\/10.1159\/000453028","journal-title":"Kidney Dis (Basel)"},{"key":"1623_CR67","doi-asserted-by":"publisher","first-page":"116775","DOI":"10.1016\/j.lfs.2019.116775","volume":"234","author":"F Sharifi","year":"2019","unstructured":"Sharifi F, Reisi P, Malek M (2019) Angiotensin 1 receptor antagonist attenuates acute kidney injury-induced cognitive impairment and synaptic plasticity via modulating hippocampal oxidative stress. Life Sci 234:116775. https:\/\/doi.org\/10.1016\/j.lfs.2019.116775","journal-title":"Life Sci"},{"key":"1623_CR68","doi-asserted-by":"publisher","first-page":"1459","DOI":"10.1007\/s11064-022-03546-8","volume":"47","author":"VK Sharma","year":"2022","unstructured":"Sharma VK, Singh TG, Prabhakar NK, Mannan A (2022) Kynurenine metabolism and Alzheimer\u2019s disease: the potential targets and approaches. Neurochem Res 47:1459\u20131476. https:\/\/doi.org\/10.1007\/s11064-022-03546-8","journal-title":"Neurochem Res"},{"key":"1623_CR69","doi-asserted-by":"publisher","DOI":"10.2174\/0125899775298987240528050110","author":"A Sharma","year":"2024","unstructured":"Sharma A, Kakkar A, Khanna M, Devi S (2024) Arbutin\u2019s potential in neuroprotection: a promising role in mitigating neurodegenerative diseases. Curr Drug Res Rev. https:\/\/doi.org\/10.2174\/0125899775298987240528050110","journal-title":"Curr Drug Res Rev"},{"key":"1623_CR70","doi-asserted-by":"publisher","first-page":"112305","DOI":"10.1016\/j.biopha.2021.112305","volume":"145","author":"R Singh","year":"2022","unstructured":"Singh R, Farooq SA, Mannan A et al (2022) Animal models of diabetic microvascular complications: relevance to clinical features. Biomed Pharmacother 145:112305. https:\/\/doi.org\/10.1016\/j.biopha.2021.112305","journal-title":"Biomed Pharmacother"},{"key":"1623_CR71","doi-asserted-by":"publisher","first-page":"069","DOI":"10.7324\/JAPS.2024.162341","volume":"14","author":"TG Singh","year":"2024","unstructured":"Singh TG, Sharma A, Devi S (2024) Exploring the mechanisms of chrysin in combating Alzheimer\u2019s disease: therapeutic perspectives. J App Pharm Sci 14,:069\u2013078. https:\/\/doi.org\/10.7324\/JAPS.2024.162341","journal-title":"J App Pharm Sci"},{"key":"1623_CR72","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.3390\/biomedicines12102387","volume":"12","author":"T Soda","year":"2024","unstructured":"Soda T, Pasqua T, De Sarro G, Moccia F (2024) Cognitive impairment and synaptic dysfunction in cardiovascular disorders: the new frontiers of the Heart-Brain Axis. Biomedicines 12:2387. https:\/\/doi.org\/10.3390\/biomedicines12102387","journal-title":"Biomedicines"},{"key":"1623_CR73","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.3233\/JAD-200473","volume":"76","author":"E Solis","year":"2020","unstructured":"Solis E, Hascup KN, Hascup ER (2020) Alzheimer\u2019s disease: the link between Amyloid-\u03b2 and neurovascular dysfunction. J Alzheimers Dis 76:1179\u20131198. https:\/\/doi.org\/10.3233\/JAD-200473","journal-title":"J Alzheimers Dis"},{"key":"1623_CR74","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1007\/s10495-006-0286-3","volume":"11","author":"SUS S\u00f8nder","year":"2006","unstructured":"S\u00f8nder SUS, Woetmann A, Odum N, Bendtzen K (2006) Spironolactone induces apoptosis and inhibits NF-kappaB independent of the mineralocorticoid receptor. Apoptosis 11:2159\u20132165. https:\/\/doi.org\/10.1007\/s10495-006-0286-3","journal-title":"Apoptosis"},{"key":"1623_CR75","doi-asserted-by":"publisher","first-page":"563","DOI":"10.3390\/brainsci10080563","volume":"10","author":"GD Stanciu","year":"2020","unstructured":"Stanciu GD, Ababei DC, Bild V et al (2020) Renal contributions in the pathophysiology and neuropathological substrates shared by chronic kidney disease and Alzheimer\u2019s disease. Brain Sci 10:563. https:\/\/doi.org\/10.3390\/brainsci10080563","journal-title":"Brain Sci"},{"key":"1623_CR76","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1038\/s41537-022-00290-4","volume":"8","author":"M Stephan","year":"2022","unstructured":"Stephan M, Schoeller J, Raabe FJ et al (2022) Spironolactone alleviates schizophrenia-related reversal learning in Tcf4 transgenic mice subjected to social defeat. Schizophrenia (Heidelb) 8:77. https:\/\/doi.org\/10.1038\/s41537-022-00290-4","journal-title":"Schizophrenia (Heidelb)"},{"key":"1623_CR77","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1210\/jcem-41-4-777","volume":"41","author":"B STRIPP","year":"1975","unstructured":"STRIPP B, TAYLOR AA, BARTTER FC et al (1975) Effect of spironolactone on sex hormones in man. J Clin Endocrinol Metabolism 41:777\u2013781. https:\/\/doi.org\/10.1210\/jcem-41-4-777","journal-title":"J Clin Endocrinol Metabolism"},{"key":"1623_CR78","doi-asserted-by":"publisher","first-page":"110820","DOI":"10.1016\/j.brainresbull.2023.110820","volume":"205","author":"C Su","year":"2023","unstructured":"Su C, Miao J, Guo J (2023) The relationship between TGF-\u03b21 and cognitive function in the brain. Brain Res Bull 205:110820. https:\/\/doi.org\/10.1016\/j.brainresbull.2023.110820","journal-title":"Brain Res Bull"},{"key":"1623_CR79","doi-asserted-by":"publisher","first-page":"35789","DOI":"10.1074\/jbc.C500238200","volume":"280","author":"BJ Tabner","year":"2005","unstructured":"Tabner BJ, El-Agnaf OMA, Turnbull S et al (2005) Hydrogen peroxide is generated during the very early stages of aggregation of the amyloid peptides implicated in alzheimer disease and Familial British dementia. J Biol Chem 280:35789\u201335792. https:\/\/doi.org\/10.1074\/jbc.C500238200","journal-title":"J Biol Chem"},{"key":"1623_CR80","doi-asserted-by":"publisher","first-page":"683","DOI":"10.1111\/j.1471-4159.2007.05072.x","volume":"104","author":"E Tamagno","year":"2008","unstructured":"Tamagno E, Guglielmotto M, Aragno M et al (2008) Oxidative stress activates a positive feedback between the gamma- and beta-secretase cleavages of the beta-amyloid precursor protein. J Neurochem 104:683\u2013695. https:\/\/doi.org\/10.1111\/j.1471-4159.2007.05072.x","journal-title":"J Neurochem"},{"key":"1623_CR81","doi-asserted-by":"publisher","first-page":"1305790","DOI":"10.3389\/fnagi.2023.1305790","volume":"15","author":"S Tan","year":"2023","unstructured":"Tan S, Chen W, Kong G et al (2023) Peripheral inflammation and neurocognitive impairment: correlations, underlying mechanisms, and therapeutic implications. Front Aging Neurosci 15:1305790. https:\/\/doi.org\/10.3389\/fnagi.2023.1305790","journal-title":"Front Aging Neurosci"},{"key":"1623_CR82","doi-asserted-by":"publisher","unstructured":"Taveggia C, Zanazzi G, Petrylak A et al (2005) Neuregulin-1 type III determines the ensheathment fate of axons. Neuron 47:681\u2013694. https:\/\/doi.org\/10.1016\/j.neuron.2005.08.017","DOI":"10.1016\/j.neuron.2005.08.017"},{"key":"1623_CR83","unstructured":"The global macroeconomic burden of Alzheimer\u2019s disease and other dementias: estimates and projections for 152 countries or territories - The Lancet Global Health. https:\/\/www.thelancet.com\/journals\/langlo\/article\/PIIS2214-109X(24)00264-X\/fulltext. Accessed 3 Mar 2025"},{"key":"1623_CR84","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1523\/JNEUROSCI.2538-10.2011","volume":"31","author":"AK Ting","year":"2011","unstructured":"Ting AK, Chen Y, Wen L et al (2011) Neuregulin 1 promotes excitatory synapse development and function in GABAergic interneurons. J Neurosci 31:15\u201325. https:\/\/doi.org\/10.1523\/JNEUROSCI.2538-10.2011","journal-title":"J Neurosci"},{"key":"1623_CR85","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.biocel.2006.07.001","volume":"39","author":"M Valko","year":"2007","unstructured":"Valko M, Leibfritz D, Moncol J et al (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39:44\u201384. https:\/\/doi.org\/10.1016\/j.biocel.2006.07.001","journal-title":"Int J Biochem Cell Biol"},{"key":"1623_CR86","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1016\/j.ad.2020.03.001","volume":"111","author":"P Vargas-Mora","year":"2020","unstructured":"Vargas-Mora P, Morgado-Carrasco D (2020) Spironolactone in dermatology: uses in acne, hidradenitis suppurativa, female pattern baldness, and hirsutism. Actas Dermosifiliogr (Engl Ed) 111:639\u2013649. https:\/\/doi.org\/10.1016\/j.ad.2020.03.001","journal-title":"Actas Dermosifiliogr (Engl Ed)"},{"key":"1623_CR87","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/1742-2094-11-85","volume":"11","author":"AR Vasconcelos","year":"2014","unstructured":"Vasconcelos AR, Yshii LM, Viel TA et al (2014) Intermittent fasting attenuates lipopolysaccharide-induced neuroinflammation and memory impairment. J Neuroinflammation 11:85. https:\/\/doi.org\/10.1186\/1742-2094-11-85","journal-title":"J Neuroinflammation"},{"key":"1623_CR88","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.3233\/JAD-160834","volume":"55","author":"P Vemuri","year":"2017","unstructured":"Vemuri P, Knopman DS, Jack CR et al (2017) Association of kidney function biomarkers with brain MRI findings: the BRINK study. J Alzheimers Dis 55:1069\u20131082. https:\/\/doi.org\/10.3233\/JAD-160834","journal-title":"J Alzheimers Dis"},{"key":"1623_CR89","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1038\/s41581-020-0266-9","volume":"16","author":"D Viggiano","year":"2020","unstructured":"Viggiano D, Wagner CA, Martino G et al (2020) Mechanisms of cognitive dysfunction in CKD. Nat Rev Nephrol 16:452\u2013469. https:\/\/doi.org\/10.1038\/s41581-020-0266-9","journal-title":"Nat Rev Nephrol"},{"key":"1623_CR90","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1016\/j.bbacli.2017.06.001","volume":"8","author":"G Vinothkumar","year":"2017","unstructured":"Vinothkumar G, Kedharnath C, Krishnakumar S et al (2017) Abnormal amyloid \u039242 expression and increased oxidative stress in plasma of CKD patients with cognitive dysfunction: A small scale case control study comparison with Alzheimer\u2019s disease. BBA Clin 8:20\u201327. https:\/\/doi.org\/10.1016\/j.bbacli.2017.06.001","journal-title":"BBA Clin"},{"key":"1623_CR91","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1161\/01.hyp.0000034738.79310.06","volume":"40","author":"A Virdis","year":"2002","unstructured":"Virdis A, Neves MF, Amiri F et al (2002) Spironolactone improves angiotensin-induced vascular changes and oxidative stress. Hypertension 40:504\u2013510. https:\/\/doi.org\/10.1161\/01.hyp.0000034738.79310.06","journal-title":"Hypertension"},{"key":"1623_CR92","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.tics.2015.12.003","volume":"20","author":"S Vogel","year":"2016","unstructured":"Vogel S, Fern\u00e1ndez G, Jo\u00ebls M, Schwabe L (2016) Cognitive adaptation under stress: a case for the mineralocorticoid receptor. Trends Cogn Sci 20:192\u2013203. https:\/\/doi.org\/10.1016\/j.tics.2015.12.003","journal-title":"Trends Cogn Sci"},{"key":"1623_CR93","doi-asserted-by":"publisher","first-page":"1077302","DOI":"10.3389\/fragi.2022.1077302","volume":"3","author":"S Wang","year":"2022","unstructured":"Wang S, Tang C, Liu Y et al (2022) Impact of impaired cerebral blood flow autoregulation on cognitive impairment. Front Aging 3:1077302. https:\/\/doi.org\/10.3389\/fragi.2022.1077302","journal-title":"Front Aging"},{"key":"1623_CR94","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.15252\/emmm.201707691","volume":"9","author":"MC Wehr","year":"2017","unstructured":"Wehr MC, Hinrichs W, Brz\u00f3zka MM et al (2017) Spironolactone is an antagonist of NRG1-ERBB4 signaling and schizophrenia-relevant endophenotypes in mice. EMBO Mol Med 9:1448\u20131462. https:\/\/doi.org\/10.15252\/emmm.201707691","journal-title":"EMBO Mol Med"},{"key":"1623_CR95","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.psyneuen.2012.09.011","volume":"38","author":"T-C Wu","year":"2013","unstructured":"Wu T-C, Chen H-T, Chang H-Y et al (2013) Mineralocorticoid receptor antagonist spironolactone prevents chronic corticosterone induced depression-like behavior. Psychoneuroendocrinology 38:871\u2013883. https:\/\/doi.org\/10.1016\/j.psyneuen.2012.09.011","journal-title":"Psychoneuroendocrinology"},{"key":"1623_CR96","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1111\/j.1532-5415.2009.02670.x","volume":"58","author":"K Yaffe","year":"2010","unstructured":"Yaffe K, Ackerson L, Kurella Tamura M et al (2010) Chronic kidney disease and cognitive function in older adults: findings from the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 58:338\u2013345. https:\/\/doi.org\/10.1111\/j.1532-5415.2009.02670.x","journal-title":"J Am Geriatr Soc"},{"key":"1623_CR97","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3390\/ijms18091965","volume":"18","author":"Y Yamazaki","year":"2017","unstructured":"Yamazaki Y, Kanekiyo T (2017) Blood-brain barrier dysfunction and the pathogenesis of Alzheimer\u2019s disease. Int J Mol Sci 18:1965. https:\/\/doi.org\/10.3390\/ijms18091965","journal-title":"Int J Mol Sci"},{"key":"1623_CR98","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.dadm.2014.12.002","volume":"1","author":"AR Zammit","year":"2015","unstructured":"Zammit AR, Katz MJ, Zimmerman ME et al (2015) Low eGFR is associated with dysexecutive and amnestic mild cognitive impairment. Alzheimers Dement (Amst) 1:152\u2013159. https:\/\/doi.org\/10.1016\/j.dadm.2014.12.002","journal-title":"Alzheimers Dement (Amst)"},{"key":"1623_CR99","doi-asserted-by":"publisher","first-page":"e3313","DOI":"10.1002\/brb3.3313","volume":"13","author":"A Zandifar","year":"2023","unstructured":"Zandifar A, Badrfam R, Gholamian F, Shafiee A (2023) Efficacy of spironolactone as adjunctive therapy to sodium valproate in bipolar-i disorder: a double-blind, randomized, placebo-controlled clinical trial. Brain Behav 13:e3313. https:\/\/doi.org\/10.1002\/brb3.3313","journal-title":"Brain Behav"},{"key":"1623_CR100","doi-asserted-by":"publisher","unstructured":"Zhang J (2019) Basic neural units of the brain: Neurons, synapses and action potential. arXiv:1906.01703:1\u201338. https:\/\/doi.org\/10.48550\/arXiv.1906.01703","DOI":"10.48550\/arXiv.1906.01703"},{"key":"1623_CR101","doi-asserted-by":"publisher","first-page":"1035","DOI":"10.3389\/fphar.2019.01035","volume":"10","author":"H Zhou","year":"2019","unstructured":"Zhou H, Tai J, Xu H et al (2019) Xanthoceraside could ameliorate Alzheimer\u2019s disease symptoms of rats by affecting the gut microbiota composition and modulating the endogenous metabolite levels. Front Pharmacol 10:1035. https:\/\/doi.org\/10.3389\/fphar.2019.01035","journal-title":"Front Pharmacol"}],"container-title":["Metabolic Brain Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01623-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11011-025-01623-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11011-025-01623-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T05:26:23Z","timestamp":1750915583000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11011-025-01623-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,29]]},"references-count":101,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["1623"],"URL":"https:\/\/doi.org\/10.1007\/s11011-025-01623-9","relation":{},"ISSN":["1573-7365"],"issn-type":[{"value":"1573-7365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,29]]},"assertion":[{"value":"4 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"The paper is submitted with the consent of all listed authors.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"194"}}